Cerebral Therapeutics
ID: 5331159A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.
5
Funding Rounds
$93.6m
Money raised
Recent Funding Rounds
Overview
A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Da**** Ab**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cerebral Therapeutics has raised a total of $47.8m in funding over 5 rounds.
Key Insights:
- Cerebral Therapeutics Series C round, June 28, 2022: $40m
- Cerebral Therapeutics Series A round, March 2019: $7.8m
- Cerebral Therapeutics Inc funding round, March 2019: $7.8m
- Cerebral Therapeutics, Inc funding round, June 2018: $3m
- Cerebral Therapeutics, Inc. funding round, January 2020: $35m
Industries
Cerebral Therapeutics is active in the following industries: